TAK · Takeda Pharmaceutical Co Ltd · Earnings Call Transcripts & Audio
Market Cap
$60.23B
Shares
3.19B
Volume · Sep 30
2.1M
Avg daily vol (3M)
3.02M
Takeda Pharmaceutical Co Ltd Earnings Call Transcripts
Quarterly earnings calls for Takeda Pharmaceutical Co Ltd (TAK), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY27 · Q1
2026-07-30
Takeda Pharmaceutical Co Ltd (TAK) Q1 2027 Earnings Call Transcript
Confident tone
Product launches (Ova-Parexidon, Rusphotide, Zasocytinib)
Horizon 1 vs Horizon 2 growth strategy
Core inline brand resiliency (Antivio, GammaGuard)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q4
2026-05-13
Takeda Pharmaceutical Co Ltd (TAK) Q4 2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q3
2026-01-29
Takeda Pharmaceutical Co Ltd (TAK) Q3 2026 Earnings Call Transcript
Confident tone
Product Launches (Ova-Parexidon, Rusphotide, Zasocytinib)
Horizon 1 / Horizon 2 Growth Framework
Core Inline Brands Resilience
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2022-12-31
Takeda Pharmaceutical Co Ltd (TAK) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 earnings calls
Key facts
CIK
1395064
CUSIP
874060205
13F (30d)
18 filings
10 filers
Visit website
Investor relations